These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1697729)

  • 1. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: Clinical and histologic correlations.
    Carcangiu ML; Chambers JT; Voynick IM; Pirro M; Schwartz PE
    Am J Clin Pathol; 1990 Sep; 94(3):247-54. PubMed ID: 1697729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part II: Correlation between biochemical and immunohistochemical methods and survival.
    Chambers JT; Carcangiu ML; Voynick IM; Schwartz PE
    Am J Clin Pathol; 1990 Sep; 94(3):255-60. PubMed ID: 1697730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
    Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
    Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial and stromal estrogen and progesterone receptor expression in endometrial cancer: true color computer-assisted image analysis versus subjective scoring.
    Kohlberger PD; Kieback DG; Breitenecker F; Loesch A; Gitsch G; Kainz C; Breitenecker G
    Gynecol Oncol; 1997 Mar; 64(3):404-10. PubMed ID: 9062141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
    Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
    Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.
    Kimura F; Watanabe J; Hata H; Fujisawa T; Kamata Y; Nishimura Y; Jobo T; Kuramoto H
    J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and immunohistochemical estrogen and progesterone receptors in adenomatous hyperplasia and endometrial carcinoma: correlations with stage and other clinicopathologic features.
    Nyholm HC; Nielsen AL; Lyndrup J; Norup P; Thorpe SM
    Am J Obstet Gynecol; 1992 Nov; 167(5):1334-42. PubMed ID: 1442987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix. An immunocytochemical study.
    Masood S; Rhatigan RM; Wilkinson EW; Barwick KW; Wilson WJ
    Cancer; 1993 Jul; 72(2):511-8. PubMed ID: 8319181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
    Reiner A; Neumeister B; Reiner G; Jakesz R; Kolb R; Schemper M; Spona J
    Zentralbl Pathol; 1991; 137(3):233-41. PubMed ID: 1657132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estrogen and progesterone receptors in endometrial carcinoma].
    Guo Y; Dang Q
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):418-21. PubMed ID: 9639729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma.
    Li SF; Shiozawa T; Nakayama K; Nikaido T; Fujii S
    Cancer; 1996 Jan; 77(2):321-9. PubMed ID: 8625241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial cancer: histologic correlates of immunohistochemical localization of progesterone receptor and estrogen receptor.
    Segreti EM; Novotny DB; Soper JT; Mutch DG; Creasman WT; McCarty KS
    Obstet Gynecol; 1989 May; 73(5 Pt 1):780-5. PubMed ID: 2704506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relation between the levels of estrogen receptor and progesterone receptor and clinicopathological status in human endometrial carcinomas].
    Yi X; Yao X
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Mar; 22(1):66-9. PubMed ID: 1774041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
    Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
    Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical analysis of uterine papillary serous carcinomas for estrogen and progesterone receptors.
    Umpierre SA; Burke TW; Tornos C; Ordonez N; Levenback C; Morris M
    Int J Gynecol Pathol; 1994 Apr; 13(2):127-30. PubMed ID: 8005733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
    Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW
    Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical assay of progesterone receptors in paraffin-embedded specimens of endometrial carcinoma and hyperplasia: a preliminary evaluation.
    Brustein S; Fruchter R; Greene GL; Pertschuk LP
    Mod Pathol; 1989 Sep; 2(5):449-55. PubMed ID: 2682614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry.
    Helin HJ; Helle MJ; Kallioniemi OP; Isola JJ
    Cancer; 1989 May; 63(9):1761-7. PubMed ID: 2649227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 expression in high-grade endometrial carcinomas--association with histologic subtype.
    Soslow RA; Shen PU; Chung MH; Isacson C; Baergen RN
    Int J Gynecol Pathol; 2000 Oct; 19(4):329-34. PubMed ID: 11109161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A; Milkov V
    Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.